Radioiodine treatment of well-differentiated thyroid cancer

被引：24
|
作者：
Wartofsky, Leonard [1 ]
Van Nostrand, Douglas [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Washington Hosp Ctr, Dept Med, Washington, DC 20010 USA
来源：
ENDOCRINE | 2012年 / 42卷 / 03期
关键词：
RECOMBINANT HUMAN THYROTROPIN; RADIOACTIVE IODINE TREATMENT; HORMONE WITHDRAWAL; FOLLOW-UP; HUMAN TSH; DOSE RADIOIODINE; REMNANT ABLATION; BONE METASTASES; 30; MCI; THERAPY;
D O I：
10.1007/s12020-012-9729-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：506 / 513
页数：8
相关论文
共 50 条
  • [31] Molecular markers for well-differentiated thyroid cancer
    Cherenko, SM
    Gorobeyko, MB
    Savchenko, VG
    [J]. EXPERIMENTAL ONCOLOGY, 2002, 24 (02) : 83 - 88
  • [32] Well-differentiated thyroid cancer: Thyroidectomy or lobectomy?
    Kluijfhout, Wouter P.
    Rotstein, Lorne E.
    Pasternak, Jesse D.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (17-18) : E517 - E520
  • [33] Molecular markers in well-differentiated thyroid cancer
    D'Cruz, Anil K.
    Vaish, Richa
    Vaidya, Abhishek
    Nixon, Iain J.
    Williams, Michelle D.
    Poorten, Vincent Vander
    Lopez, Fernando
    Angelos, Peter
    Shaha, Ashok R.
    Khafif, Avi
    Skalova, Alena
    Rinaldo, Alessandra
    Hunt, Jennifer L.
    Ferlito, Alfio
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (06) : 1375 - 1384
  • [34] Molecular markers in well-differentiated thyroid cancer
    Anil K. D’Cruz
    Richa Vaish
    Abhishek Vaidya
    Iain J. Nixon
    Michelle D. Williams
    Vincent Vander Poorten
    Fernando López
    Peter Angelos
    Ashok R. Shaha
    Avi Khafif
    Alena Skalova
    Alessandra Rinaldo
    Jennifer L. Hunt
    Alfio Ferlito
    [J]. European Archives of Oto-Rhino-Laryngology, 2018, 275 : 1375 - 1384
  • [35] Conservative management of well-differentiated thyroid cancer
    Hassanain, Mazen
    Wexler, Marvin
    [J]. CANADIAN JOURNAL OF SURGERY, 2010, 53 (02) : 109 - 118
  • [36] Management of the Neck in Well-Differentiated Thyroid Cancer
    Panagiotis Asimakopoulos
    Ashok R. Shaha
    Iain J. Nixon
    Jatin P. Shah
    Gregory W. Randolph
    Peter Angelos
    Mark E. Zafereo
    Luiz P. Kowalski
    Dana M. Hartl
    Kerry D. Olsen
    Juan P. Rodrigo
    Vincent Vander Poorten
    Antti A. Mäkitie
    Alvaro Sanabria
    Carlos Suárez
    Miquel Quer
    Francisco J. Civantos
    K. Thomas Robbins
    Orlando Guntinas-Lichius
    Marc Hamoir
    Alessandra Rinaldo
    Alfio Ferlito
    [J]. Current Oncology Reports, 2021, 23
  • [37] Biologic basis for the treatment of microscopic, occult well-differentiated thyroid cancer
    Furlan, JC
    Bedard, Y
    Rosen, LB
    [J]. SURGERY, 2001, 130 (06) : 1050 - 1054
  • [38] Evaluation and treatment of persistent thyroglobulinemia in patients with well-differentiated thyroid cancer
    Pachucki, J
    Burmeister, LA
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 137 (03) : 254 - 261
  • [39] Quality of life with well-differentiated thyroid cancer: Treatment toxicities and their reduction
    Mendoza, A
    Shaffer, B
    Karakla, D
    Mason, ME
    Elkins, D
    Goffman, TE
    [J]. THYROID, 2004, 14 (02) : 133 - 140
  • [40] Outcome in well-differentiated follicular thyroid carcinoma after radioiodine ablation therapy
    Biermann, K.
    Brockmann, H.
    Ezziddin, S.
    Ahmadzadehfar, H.
    Haslerud, T.
    Sabet, A.
    Biersack, H. J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S451 - S451
12345